Why This Seattle Biotech Could be an M&A Target Post author:Sam Post published:January 18, 2018 Post category:BioPharma Immune Design is a clinical-stage immunotherapy company. Source: BioSpace You Might Also Like 3 Biotechs Facing Stiff Headwinds in 2018 February 13, 2018 3 Ways Fitbit Stock Can Double From Here March 8, 2017 Massachusetts' Selecta Banks $50 Million June 25, 2017
